INSIGHT and NORDIL - Reply

被引：6

作者：

Kjeldsen, SE

Westheim, AS

Os, I ^{[1
]}

机构：

[1] Ulleval Univ Hosp, Dept Nephrol, N-0407 Oslo, Norway

[2] Ulleval Univ Hosp, Dept Cardiol, N-0407 Oslo, Norway

来源：

LANCET | 2000年 / 356卷 / 9245期

关键词：

D O I：

10.1016/S0140-6736(05)73480-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1929 / 1930

页数：2

共 6 条

[1] Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT) [J].

Brown, MJ ;

Palmer, CR ;

Castaigne, A ;

de Leeuw, PW ;

Mancia, G ;

Rosenthal, T ;

Ruilope, LM .

LANCET, 2000, 356 (9227) :366-372

[2]

Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967

[3] Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension:: the Nordic Diltiazem (NORDIL) study [J].

Hansson, L ;

Hedner, T ;

Lund-Johansen, P ;

Kjeldsen, SE ;

Lindholm, LH ;

Syvertsen, JO ;

Lanke, J ;

de Faire, U ;

Dahlöf, B ;

Karlberg, BE .

LANCET, 2000, 356 (9227) :359-365

[4] Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension:: the Captopril Prevention Project (CAPPP) randomised trial [J].

Hansson, L ;

Lindholm, LH ;

Niskanen, L ;

Lanke, J ;

Hedner, T ;

Niklason, A ;

Luomanmäki, K ;

Dahlöf, B ;

de Faire, U ;

Mörlin, C ;

Karlberg, BE ;

Wester, PO ;

Björck, JE .

LANCET, 1999, 353 (9153) :611-616

[5] Randomised trial of old and new antihypertensive drugs in elderly patients:: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study [J].

Hansson, L ;

Lindholm, LH ;

Ekbom, T ;

Dahlöf, B ;

Lanke, J ;

Scherstén, B ;

Wester, PO ;

Hedner, T ;

de Faire, U .

LANCET, 1999, 354 (9192) :1751-1756

[6]

2000, LANCET, V356, P867

← 1 →